| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
674,040,000 |
| Market
Cap: |
16.23(B) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$17.15 - $26.07 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Avantor is a global manufacturer and distributor that provides products and services to customers in the biopharmaceutical, healthcare, education and government and advanced technologies and applied materials industries. Co.'s portfolio includes: Materials and consumables, such as lab products and supplies, formulated silicone materials, customized excipients, and customized single-use assemblies; equipment and instrumentation, such as filtration systems, virus inactivation systems, and incubators; and services and specialty procurement, such as onsite lab and production, clinical, equipment, procurement and sourcing and biopharmaceutical material scale-up and development services.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
27,500 |
| Total Buy Value |
$0 |
$0 |
$0 |
$573,100 |
| Total People Bought |
0 |
0 |
0 |
2 |
| Total Buy Transactions |
0 |
0 |
0 |
2 |
| Total Shares Sold |
3,685 |
27,872 |
60,449 |
104,821 |
| Total Sell Value |
$94,447 |
$687,456 |
$1,380,595 |
$2,464,073 |
| Total People Sold |
1 |
3 |
4 |
5 |
| Total Sell Transactions |
1 |
4 |
6 |
13 |
| End Date |
2024-03-03 |
2023-12-01 |
2023-06-02 |
2022-06-02 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Szlosek Thomas A |
EVP & CFO |
• – – |
2020-02-21 |
4 |
A |
$0.00 |
$0 |
D/D |
33,956 |
287,421 |
|
- |
|
| Vanderhaegen Frederic |
EVP, Europe |
• – – |
2020-02-21 |
4 |
A |
$0.00 |
$0 |
D/D |
28,297 |
239,641 |
|
- |
|
| Couturier Christophe |
EVP, Services |
• – – |
2020-02-21 |
4 |
A |
$0.00 |
$0 |
D/D |
16,978 |
174,121 |
|
- |
|
| Wondrasch Michael |
EVP, CIO |
• – – |
2020-02-21 |
4 |
A |
$0.00 |
$0 |
D/D |
16,978 |
186,199 |
|
- |
|
| Mcallister Eric |
EVP & Chief HR Officer |
• – – |
2020-02-21 |
4 |
A |
$0.00 |
$0 |
D/D |
16,978 |
216,029 |
|
- |
|
| Gupta Rajiv |
Director |
– • – |
2020-02-21 |
4 |
A |
$0.00 |
$0 |
D/D |
11,319 |
565,746 |
|
- |
|
| Ohri Devashish |
EVP, IMEA |
• – – |
2020-02-21 |
4 |
A |
$0.00 |
$0 |
D/D |
11,319 |
168,462 |
|
- |
|
| Peacock Jonathan M |
Director |
– • – |
2020-02-21 |
4 |
A |
$0.00 |
$0 |
D/D |
11,319 |
161,195 |
|
- |
|
| Foxe Tanya |
EVP, Operations & Supply Chain |
• – – |
2020-02-21 |
4 |
A |
$0.00 |
$0 |
D/D |
20,751 |
39,458 |
|
- |
|
| Brophy Gerard |
EVP, Biopharma Production |
• – – |
2020-02-21 |
4 |
A |
$0.00 |
$0 |
D/D |
24,524 |
235,868 |
|
- |
|
| Bramwell James |
EVP, Strategic Partners |
• – – |
2020-02-21 |
4 |
A |
$0.00 |
$0 |
D/D |
11,319 |
139,890 |
|
- |
|
| Andres Juan |
Director |
– • – |
2020-02-21 |
4 |
A |
$0.00 |
$0 |
D/D |
11,319 |
14,951 |
|
- |
|
| Shaw Christi |
Director |
– • – |
2020-02-21 |
4 |
A |
$0.00 |
$0 |
D/D |
11,319 |
25,605 |
|
- |
|
| Stubblefield Michael |
CEO |
• • – |
2020-02-21 |
4 |
A |
$0.00 |
$0 |
D/D |
141,483 |
1,175,635 |
|
- |
|
| Ohri Devashish |
EVP, IMEA |
• – – |
2020-02-18 |
4 |
S |
$17.54 |
$350,800 |
D/D |
(20,000) |
157,143 |
|
5% |
|
| Ohri Devashish |
EVP, IMEA |
• – – |
2020-02-18 |
4 |
OE |
$1.60 |
$32,000 |
D/D |
20,000 |
177,143 |
|
- |
|
| Henrichwark Sven |
EVP, APAC Region |
• – – |
2020-01-21 |
4 |
A |
$0.00 |
$0 |
D/D |
14,375 |
14,375 |
|
- |
|
| Brophy Gerard |
EVP, Biopharma Production |
• – – |
2020-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
54,201 |
211,344 |
|
- |
|
| Szlosek Thomas A |
EVP & CFO |
• – – |
2020-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
67,751 |
253,465 |
|
- |
|
| Vanderhaegen Frederic |
EVP, Europe |
• – – |
2020-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
54,201 |
211,344 |
|
- |
|
| Wondrasch Michael |
EVP, CIO |
• – – |
2020-01-02 |
4 |
A |
$0.00 |
$0 |
D/D |
40,650 |
169,221 |
|
- |
|
| Foxe Tanya |
EVP, Operations & Supply Chain |
• – – |
2019-09-30 |
4 |
A |
$0.00 |
$0 |
D/D |
18,707 |
18,707 |
|
- |
|
| Connolly Thomas |
Director |
– • – |
2019-09-25 |
4 |
S |
$14.70 |
$369,526 |
I/I |
(25,000) |
72,620,082 |
|
- |
|
| Connolly Thomas |
Director |
– • – |
2019-09-25 |
4 |
B |
$14.70 |
$369,526 |
I/I |
25,000 |
72,630,004 |
2.1 |
- |
|
| Natauri Jo |
Director |
– • – |
2019-09-25 |
4 |
S |
$14.70 |
$369,526 |
I/I |
(25,000) |
72,620,082 |
|
- |
|
534 Records found
|
|
Page 18 of 22 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
0.48 (2.03%) 
